These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7728270)

  • 1. [Use of immunoglobulins G in the treatment of nervous system diseases].
    Schuller E
    Transfus Clin Biol; 1995; 2(1):57-66. PubMed ID: 7728270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases.
    Elovaara I; Apostolski S; van Doorn P; Gilhus NE; Hietaharju A; Honkaniemi J; van Schaik IN; Scolding N; Soelberg Sørensen P; Udd B;
    Eur J Neurol; 2008 Sep; 15(9):893-908. PubMed ID: 18796075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic aspects of neurologic and neuromuscular diseases.
    Smith DR; Weiner HL
    JAMA; 1997 Dec; 278(22):1956-61. PubMed ID: 9396658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The current place of high-dose immunoglobulins in the treatment of neuromuscular disorders.
    van der Meché FG; van Doorn PA
    Muscle Nerve; 1997 Feb; 20(2):136-47. PubMed ID: 9040650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy with immunoglobulins in neurologic autoimmune diseases. Indications and mechanism of action].
    Gold R; Hartung HP; Toyka KV
    Fortschr Neurol Psychiatr; 1995 Jan; 63(1):17-29. PubMed ID: 7883268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [American Academy of Neurology, New Orleans, 21-28 April 2012].
    Benatru I; de Toffol B; Léger JM; Thomas-Antérion C; Sellal F; Sibon I; Pierrot-Deseilligny C
    Rev Neurol (Paris); 2012 Jun; 168(6-7):552-65. PubMed ID: 22647808
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of autoimmune neuromuscular diseases with high-dose intravenous immune globulin.
    Soueidan SA; Dalakas MC
    Pediatr Res; 1993 Jan; 33(1 Suppl):S95-100. PubMed ID: 8433882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulin in autoimmune neuromuscular diseases.
    Dalakas MC
    JAMA; 2004 May; 291(19):2367-75. PubMed ID: 15150209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of intravenous gamma globulins in neuroimmunologic diseases.
    Latov N; Chaudhry V; Koski CL; Lisak RP; Apatoff BR; Hahn AF; Howard JF
    J Allergy Clin Immunol; 2001 Oct; 108(4 Suppl):S126-32. PubMed ID: 11586280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neurology].
    Botez S; Carota A; Dunand M; Du Pasquier R; Kuntzer T; Michel P; Morier J; Schluep M; Rossetti AO
    Rev Med Suisse; 2007 Jan; 3(93):39-47. PubMed ID: 17354660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of intravenous immunoglobulin for treatment of neurologic conditions: a systematic review.
    Fergusson D; Hutton B; Sharma M; Tinmouth A; Wilson K; Cameron DW; Hebert PC
    Transfusion; 2005 Oct; 45(10):1640-57. PubMed ID: 16181216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma-exchange in neurological diseases.
    Valbonesi M; Garelli S; Montani F; Mosconi L; Beltramelli A; Zerbi D; Sardella M
    Ric Clin Lab; 1983; 13(1):75-84. PubMed ID: 6857098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 20. Immunologic neuromuscular disorders.
    Chitnis T; Khoury SJ
    J Allergy Clin Immunol; 2003 Feb; 111(2 Suppl):S659-68. PubMed ID: 12592311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromuscular diseases account for a major burden in the field of neurological diseases in the wealthy part of the world.
    Léger JM
    Curr Opin Neurol; 2012 Oct; 25(5):521-2. PubMed ID: 22960497
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of intravenous immunoglobulin in neurological disorders].
    Steck AJ
    Rev Med Suisse; 2005 Apr; 1(17):1167-70. PubMed ID: 15941089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standards of care for patients with neurological disease. A consensus. Report of a working group. Research Unit, Royal College of Physicians, London.
    J R Coll Physicians Lond; 1990 Apr; 24(2):90-7. PubMed ID: 2352202
    [No Abstract]   [Full Text] [Related]  

  • 17. Guidelines for the use of intravenous immunoglobulin in the treatment of neurologic diseases.
    Bascić-Kes V; Kes P; Zavoreo I; Lisak M; Zadro L; Corić L; Demarin V;
    Acta Clin Croat; 2012 Dec; 51(4):673-83. PubMed ID: 23540178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of therapeutic plasmapheresis for neurological disorders.
    Natl Inst Health Consens Dev Conf Consens Statement; 1986; 6(4):1-7. PubMed ID: 3537747
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of intravenous immunoglobulin and plasma exchange in neurological disease.
    Linker RA; Gold R
    Curr Opin Neurol; 2008 Jun; 21(3):358-65. PubMed ID: 18451723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin therapy for neurological disorders.
    Harkins C; Hammond-Tooke G; Faed J
    N Z Med J; 2009 Oct; 122(1305):41-6. PubMed ID: 19966877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.